Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma ; volume:9 ; number:1 ; day:15 ; month:12 ; year:2009 ; pages:1-9 ; date:12.2009
BMC cancer ; 9, Heft 1 (15.12.2009), 1-9, 12.2009
- Urheber
-
Scaruffi, Paola
- Beteiligte Personen und Organisationen
-
Stigliani, Sara
Moretti, Stefano
Coco, Simona
De Vecchi, Carla
Valdora, Francesca
Garaventa, Alberto
Bonassi, Stefano
Tonini, Gian Paolo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-441
- URN
-
urn:nbn:de:1111-2016030351266
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scaruffi, Paola
- Stigliani, Sara
- Moretti, Stefano
- Coco, Simona
- De Vecchi, Carla
- Valdora, Francesca
- Garaventa, Alberto
- Bonassi, Stefano
- Tonini, Gian Paolo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcribed-ultra conserved region expression profiling from low-input total RNA
Assessing the genomic evidence for conserved transcribed pseudogenes under selection
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Expressional alterations in functional ultra-conserved non-coding rnas in response to all-transretinoic acid - induced differentiation in neuroblastoma cells
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Bacteroides expand the functional versatility of a conserved transcription factor and transcribed DNA to program capsule diversity
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Transcribed-ultra conserved region expression profiling from low-input total RNA
Assessing the genomic evidence for conserved transcribed pseudogenes under selection
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Expressional alterations in functional ultra-conserved non-coding rnas in response to all-transretinoic acid - induced differentiation in neuroblastoma cells
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Bacteroides expand the functional versatility of a conserved transcription factor and transcribed DNA to program capsule diversity
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Transcribed-ultra conserved region expression profiling from low-input total RNA
Assessing the genomic evidence for conserved transcribed pseudogenes under selection
Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death
Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma
Expressional alterations in functional ultra-conserved non-coding rnas in response to all-transretinoic acid - induced differentiation in neuroblastoma cells
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma
Functional validation of novel target structures for treatment of high-risk neuroblastoma
Bacteroides expand the functional versatility of a conserved transcription factor and transcribed DNA to program capsule diversity
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma